Antitumor effects of vitamin A and inhibitors of ornithine decarboxylase in cultured neuroblastoma and glioma cells.
D000818:Animals; D000970:Antineoplastic Agents; D002262:Carboxy-Lyases / Q000037:antagonists & inhibitors*; D002455:Cell Division / Q000187:drug effects; D002460:Cell Line; D004353:Drug Evaluation, Preclinical; D000518:Eflornithine; D005910:Glioma / Q000503:physiopathology*; D051379:Mice; D009447:Neuroblastoma / Q000503:physiopathology*; D009952:Ornithine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D065108:Ornithine Decarboxylase Inhibitors; D051381:Rats; D012172:Retinaldehyde / Q000494:pharmacology; D014212:Tretinoin / Q000494:pharmacology; D014801:Vitamin A / Q000494:pharmacology*
D000970:Antineoplastic Agents; D065108:Ornithine Decarboxylase Inhibitors; D014801:Vitamin A; D014212:Tretinoin; D009952:Ornithine; D002262:Carboxy-Lyases; D012172:Retinaldehyde; D000518:Eflornithine